November 18, 2013
–Continued reduction in cardiovascular events and no safety concerns observed through three years of follow up in the MYDICAR high dose group-–Oral Presentation by Dr. Barry H. Greenberg at 9 AM CET on November 19, 2013 — Celladon Corporation, a clinicalstage biotechnology company focused on developing novel therapies by applying its leadershipposition in the field...


Seven research institutions receive DKK 20 million for coronavirus research
1. April 2020
How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge